Marcel Arias-Badia

5PUBLICATIONS
15CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 20, 2026
Functionally heterogeneous intratumoral CD4+CD8+ double-positive T cells can give rise to single-positive T cells.

Tony Li, Arielle Ilano, Marcel Arias-Badia

|Apr 03, 2025
Impact of tumor localization on antitumor immunity with conditionally activated CTLA-4 blockade.

Marcel Arias-Badia, Chien-Chun Steven Pai, Yee May Lwin

|Dec 05, 2024
Evolution of myeloid-mediated immunotherapy resistance in prostate cancer.

Aram Lyu, Zenghua Fan, Matthew Clark

|Jul 26, 2024
γδ T cells as critical anti-tumor immune effectors.

Marcel Arias-Badia, Ryan Chang, Lawrence Fong

|Mar 17, 2023
Exhausted intratumoral Vδ2- γδ T cells in human kidney cancer retain effector function.

Chiara Rancan, Marcel Arias-Badia, Pranay Dogra

Pageof 1